Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Technical Note
Protocol
Product Sheet
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
TwinStrand Biosciences discusses Duplex Sequencing
Dr. Jesse Salk reviews using Duplex Sequencing to measure ultra-rare mutations from carcinogens, aging, and the earliest stages of cancer.
Presented by
Jesse Salk, MD, PhD
TwinStrand Biosciences
RECORDED AT AACR 2019
Covered in this Webinar
Goals of TwinStrand Biosciences
Duplex Sequencing technology versus standard sequencing
Capturing ultra-rare mutations from sequencing data
Jesse Salk, MD, PhD, Co-Founder, CEO, TwinStrand Biosciences explains the utility of duplex sequencing. Duplex Sequencing is an NGS error-correction method which increases accuracy by more than 10,000-fold and enables high-confidence detection of ultra-rare mutations. This webinar presents applications of Duplex Sequencing in early cancer detection, monitoring for residual disease, evolution of drug resistance, and cancer risk assessment of new drugs and chemicals.
Share your details to Watch the Webinar
